Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant

Blood

Volumn 116, Issue 18, 2010, Pages 3526-3536

  Freire, Teresa ^a,b,c   Zhang, Xiaoming ^a,b   Dériaud, Edith ^a,b   Ganneau, Christelle ^a,c   Vichier Guerre, Sophie ^a,c   Azria, Elie ^d,e   Launay, Odile ^b,e,f   Lo Man, Richard ^a,b   Bay, Sylvie ^a,c   Leclerc, Claude ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c CNRS   (France)

^d BICHAT HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Groupe Hospitalier Bichat Claude Bernard ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CYTOSINE; GLYCOPEPTIDE TN3; GUANOSINE; LECTIN; MACROPHAGE GALACTOSE TYPE LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MULTIPLE ANTIGENIC GLYCOPEPTIDE; PHOSPHATE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG BINDING; GERMINAL CENTER; GLYCOSYLATION; IMMUNE RESPONSE; IMMUNIZATION; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SKIN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 78149340104     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-279133     Document Type: Article

References (48)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419-426.
2. Tacken PJ, de Vries IJ, Torensma R, et al. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol. 2007;7(10):790-802. (Pubitemid 47480309)
3. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev. 1998;163:19-34. (Pubitemid 28327859)
4. Zhang SS, Park CG, Zhang P, et al. Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. J Biol Chem. 2008;283(46):31511-31521.
5. Cambi A, Netea MG, Mora-Montes HM, et al. Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem. 2008;283(29):20590-20599.
6. Lambert AA, Gilbert C, Richard M, et al. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood. 2008;112(4):1299-1307.
7. McGreal EP, Miller JL, Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors. Curr Opin Immunol. 2005;17(1):18-24.
8. Huysamen C, Brown GD. The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol Lett. 2009;290(2):121-128.
9. Tang CK, Sheng KC, Apostolopoulos V, et al. Protein/peptide and DNA vaccine delivery by targeting C-type lectin receptors. Expert Rev Vaccines. 2008;7(7):1005-1018.
10. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315(5808):107-111.
11. Sancho D, Mourão-Sá D, Joffre OP, et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest. 2008;118(6):2098-2110.
12. Keler T, Ramakrishna V, Fanger MW. Mannose receptor-targeted vaccines. Expert Opin Biol Ther. 2004;4(12):1953-1962.
13. Kawakami K, Yamamoto K, Toyoshima S, et al. Dual function of macrophage galactose/N-acetylgalactosamine-specific lectins: glycoprotein uptake and tumoricidal cellular recognition. Jpn J Cancer Res. 1994;85(7):744-749. (Pubitemid 24228409)
14. Valladeau J, Duvert-Frances V, Pin JJ, et al. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol. 2001;167(10):5767-5774.
15. van Vliet SJ, Saeland E, van Kooyk Y. Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol. 2008;29(2):83-90.
16. Suzuki N, Yamamoto K, Toyoshima S, et al. Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen. J Immunol. 1996;156(1):128-135.
17. Tsuiji M, Fujimori M, Ohashi Y, et al. Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J Biol Chem. 2002;277(32):28892- 28901.
18. Denda-Nagai K, Kubota N, Tsuiji M, et al. Macrophage C-type lectin on bone marrow-derived immature dendritic cells is involved in the internalization of glycosylated antigens. Glycobiology. 2002;12(7):443-450.
19. Kumamoto Y, Denda-Nagai K, Aida S, et al. MGL2 Dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo. PLoS ONE. 2009;4(5):e5619.
20. Lo-Man R, Vichier-Guerre S, Bay S, et al. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope. J Immunol. 2001;166(4):2849-2854. (Pubitemid 32173527)
21. Freire T, Lo-Man R, Piller F, et al. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for anti-tumor vaccination. Glycobiology. 2006;16(5):390-401.
22. Lo-Man R, Vichier-Guerre S, Perraut R, et al. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in non-human primates. Cancer Res. 2004;64(14):4987-4994. (Pubitemid 38924547)
23. Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 1996;184(2):695-706. (Pubitemid 26324123)
24. Henri S, Siret C, Machy P, et al. Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen. Eur J Immunol. 2007;37(5):1184-1193. (Pubitemid 46925303)
25. Leclerc C, Deriaud E, Mimic V, et al. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J Virol. 1991;65(2):711-718.
26. Lo-Man R, Langeveld JP, Deriaud E, et al. Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle. Infect Immun. 2000;68(6):3079-3089. (Pubitemid 30340393)
27. Zhang X, Deriaud E, Jiao X, et al. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med. 2007;204(5):1107-1118. (Pubitemid 46798154)
28. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol. 2008;8(12):935-947.
29. Allan RS, Waithman J, Bedoui S, et al. Migratory dendritic cells transfer antigen to a lymph noderesident dendritic cell population for efficient CTL priming. Immunity. 2006;25(1):153-162.
30. Itano AA, McSorley SJ, Reinhardt RL, et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 2003;19(1):47-57.
31. Cervenak L, Magyar A, Boja R, et al. Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells. Immunol Lett. 2001;78(2):89-96.
32. Fazilleau N, Mark L, McHeyzer-Williams LJ, et al. Follicular helper T cells: lineage and location. Immunity. 2009;30(3):324-335.
33. Sokol CL, Chu NQ, Yu S, et al. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol. 2009;10(7):713-720.
34. Napoletano C, Rughetti A, Agervig Tarp MP, et al. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res. 2007;67(17):8358-8367. (Pubitemid 47395175)
35. Denda-Nagai K, Aida S, Saba K, et al. Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): Efficient uptake and presentation of glycosylated antigens by dendritic cells. J Biol Chem. 2010;285(25):19193-19204.
36. Caminschi I, Proietto AI, Ahmet F, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 2008;112(8):3264-3273.
37. Bedoui S, Whitney PG, Waithman J, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol. 2009;10(5):488-495.
38. Kim TS, Braciale TJ. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE. 2009;4(1):e4204.
39. Ballesteros-Tato A, Leon B, Lund FE, et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol. 2010;11(3):216-224.
40. Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654. (Pubitemid 40719199)
41. Nagao K, Ginhoux F, Leitner WW, et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A. 2009;106(9):3312-3317.
42. Klechevsky E, Morita R, Liu M, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 2008;29(3):497-510.
43. van Vliet SJ, Paessens LC, Broks-van den Berg VC, et al. The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs. J Immunol. 2008;181(5):3148-3155.
44. Leibundgut-Landmann S, Osorio F, Brown GD, et al. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood. 2008;112(13):4971-4980.
45. van Vliet SJ, van Liempt E, Saeland E, et al. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int Immunol. 2005;17(5):661-669.
46. Saeland E, van Vliet SJ, Bäckström M, et al. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol Immunother. 2007;56(8):1225-1236.
47. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 2006;7(6):599-604. (Pubitemid 43827326)
48. Osinaga E. Expression of cancer-associated simple mucin-type O-glycosylated antigens in parasites. IUBMB Life. 2007;59(4-5):269-273. (Pubitemid 46763773)